The drug company lowered its 2010 revenue forecast, citing weakness in the euro
Today’s column includes the latest quarterly results from Amgen, Inc. (AMGN), a wave of post-earnings price-target adjustments on Potash Corp…( Read More )
Read more on Schaeffers Research
Leave a Reply